Objective. To describe and communicate data collected in the CHEER (Creating Healthcare Excellence through Education and Research) infrastructure proof-of-concept study to facilitate understanding of the potential capabilities of practicebased research networks and to present pilot data for development of future research initiatives.
Institute on Deafness and Other Communication Disorders, they have disease-specific measures, and evidence-based treatment literature is limited. A second goal of the project was to develop databases to further characterize the symptoms of patients presenting with tinnitus and dizziness to inform future research in these areas.
Disease-Specific Measures: Tinnitus and Dizziness
Evaluation and treatment of tinnitus and dizziness contribute significant costs to the health care system and are inadequately understood because of the heterogeneity of causes and clinical presentations. According to the American Tinnitus Association, 50 million Americans experience tinnitus and 12 million experience symptoms that are severe enough to seek medical attention. Two million patients are so seriously debilitated that they cannot function on a normal day-to-day basis. The financial impact of tinnitus is significant. Disability awards were received by 289,159 veterans for their tinnitus, totaling $345,495,552 in annual compensation (2004) . 1 This is just one example of the cost to society and does not reflect other quality-of-life impacts.
Dizziness and vertigo are frequent complaints of patients seen in otolaryngology offices, and tools for evaluation and treatment are often inadequate. In studies by Neuhauser et al, 2, 3 dizziness and vertigo present a 1-year prevalence of 20% and a 1-year incidence of 3% in a general population. The impact of dizziness on cost and quality of life is considerable. 4 One-fourth of patients with chronic dizziness reduce work hours, change occupations, or stop working as a result of their dizziness, and half indicate a substantial reduction in their efficiency at work. 4 Two prior reports on the CHEER network discuss in more detail its development, structure, and progress. 5, 6 This third report on the CHEER network summarizes the data collected through the ODC project. Methodologically, the structure of the study was driven by the project's primary intent of testing the network's ability to deploy a project. In this report, we describe the data that were the by-product of the research methodology, providing an innovative and potentially compelling picture of the future of comparative effectiveness research, particularly where precise disease definitions are still under debate.
Methods
In January 2010, 2 CHEER multidisciplinary expert panels were convened to identify evidence gaps and research priorities within tinnitus and dizziness. The ODC project was proposed by the CHEER hub principal investigators (PIs) and was vetted further at these meetings, accessing multidisciplinary input for consensus on the final set of study questionnaires and surveys. The resulting survey set included patient surveys, including the Tinnitus Handicap Inventory (THI), 7 the Dizziness Handicap Inventory (DHI), 8 and the Migraine Assessment Tool, 9 as well as background questions and demographics. The physician portion included associated clinical information and diagnosis.
To protect patient privacy, study surveys were given a unique identifier number and stripped of patient identifiers. All research data were stored in a central database, accessible to all participating sites for online entry in REDCap, a secure research data system. The Duke University institutional review board (IRB) approved this study for exemption and extended to CHEER community sites. CHEER sites participating in the study requiring an independent IRB review (n = 5) were provided administrative support.
A convenience sample of patients presenting for visits for tinnitus and/or dizziness participated in the project. No compensation was provided to the patient or the participating CHEER sites. Eligible patients had to be ≥18 years of age, literate and able to read and speak English or able to participate with the aid of a medical interpreter, possess sufficient mental capacity to comply with study requirements, and present to clinic with symptoms of tinnitus/dizziness.
The project was launched in February 2010 with rolling activation of sites (timing based on their readiness given IRB needs and/or internal process setup) beginning in March 2010 and continued through November 2010. Data were extracted from the REDCap database and analyzed using summary SAS reports (SAS Institute, Cary, North Carolina).
Results

Description of Participating Sites and Enrolled Patients
Of the active trained sites in the CHEER network, 16 of 22 (73%) across 13 states participated in the ODC project (see Acknowledgments). Nine sites (56%) were private practices and 7 were academic. A total of 1532 patients were enrolled with average and median enrollment of 95.8 and 64.5 patients per site, respectively.
Patient demographics are provided in Table 1 ; 16% of the patients indicated a race other than white.
Thirty-four percent of patients indicated their main concern was dizziness, 28% indicated tinnitus, 29% indicated both tinnitus and dizziness, and the remaining 9% provided no response to this question but completed other sections of the survey packet. This is important to note as patient surveys were not removed from the analysis if they skipped questions. Appropriate denominators for the various subsections of the report are noted in corresponding tables.
Data are stratified by the patient-reported main concern to highlight different patient profiles. Patients with primarily tinnitus or dizziness alone may look very different from patients with both tinnitus and dizziness, and their underlying demographics and/or contributing factors may vary as well as their responsiveness to particular treatments ( Table 1) . Table 2 details the profile of tinnitus patient respondents. The majority of tinnitus and dizziness (76%, n = 336) and tinnitus (68%, n = 287) patients responded that their tinnitus began more than 6 months ago. Approximately one-third of patients indicated extreme bother from tinnitus but could carry out activities of daily living, whereas another one-third indicated that their tinnitus was only a problem on certain days. Of tinnitus and dizziness patients, 15% indicated that their tinnitus was so extreme that it affected their life greatly as compared with 7% of tinnitus patients.
Tinnitus
Data collected on strategies tried by the patients could help future subtyping therapeutic studies. For example, for tinnitus and dizziness patients, the top 3 strategies that patients indicated worked "sometimes" or "always" (and had denominators of patients greater than 20) were background sound (56/63 or 89%), antianxiety medicine (45/52 or 87%), and other medications (65/74 or 87%). Using the same criteria, the top 3 strategies for tinnitus patients were background sound (57/67 or 85%), amplification (15/24 or 63%), and antianxiety medicine (20/37 or 54%). On average, patients indicated they had tried 2.25 strategies with a maximum of 10 and a median of 2 strategies tried.
The average THI (high score worse, 0-100) score for tinnitus and dizziness patients was 36.5 as compared with 28.6 for tinnitus patients, both a grade of 2 (mild severity). For tinnitus and dizziness patients, 22% fell into grades 4 (severe) and 5 (catastrophic) as compared with 12% of tinnitus patients. The most frequently reported problem/item on the THI for both tinnitus + dizziness and tinnitus patients was "I feel I have no control over my tinnitus," whereas the least frequently reported problem/item was "I feel desperate because of my tinnitus."
Provider data ( Table 3 ) collected on tinnitus patients included the provider's determination of whether the tinnitus was subjective or objective and audiogram information. For the tinnitus and dizziness patients in the study, tinnitus was determined to be objective in 3% of the patients vs 6% of the tinnitus patients. When the audiogram was performed, it showed normal hearing in both ears one-fifth of the time. Patients were allowed to skip questions, which results in changing denominators by question and throughout the survey.
Dizziness Table 4 provides the results of the survey detailing the profile of dizziness patient respondents. The majority of tinnitus and dizziness (85%, n = 351) and dizziness (82%, n = 407) patients responded that their dizziness was severe enough to warrant further investigation of their experience. The specific screening question was worded as follows: Patients responding to the dizziness portions of the questionnaire reported that dizziness had an impact on their quality of life and daily living. Thirty-nine percent of dizziness and 26% of tinnitus and dizziness patients had more than 10 vertigo episodes in the last month, and 23% of tinnitus and dizziness and 24% of dizziness patients missed more than 10 days of work in that same timeframe. Tinnitus and dizziness patients had associated symptoms more often than dizziness patients; however, the top associated symptoms differed by group. The top 2 associated symptoms for tinnitus and dizziness were tinnitus in predominantly 1 ear (54%, n = 207) and fullness or pressure in 1 ear only (47%), whereas the top 2 associated symptoms for dizziness patients were headache or head pain (32%) and light sensitivity (25%). Neck pain, headaches previously diagnosed as migraines, and family history of migraine were present a third of the time or more in both groups.
The average DHI 8 (higher scores worse, 0-100) score for tinnitus and dizziness patients was 41.7 compared with 40.0 for dizziness patients, both a grade of 2 (moderate severity). For tinnitus and dizziness patients, 24% were grade 3 (severe) compared with 18% of dizziness patients. The most frequently reported problem/item on the DHI for both tinnitus + dizziness and dizziness patients was "quick head movements increase problem," whereas the least frequently reported problem/item was "afraid to stay home alone." For the subgroup of dizzy patient respondents who filled out the Migraine Assessment Tool (MAT), 9 27% of both groups scored as having a diagnosis of migraine.
Physician data ( Table 5 ) collected on dizziness patients included the provider's determination of "most likely diagnosis" and audiogram and electronystagmography (ENG) information. The top 3 "most likely diagnoses" for the tinnitus and dizziness patients were definite Ménière disease (38%, n = 103), vertiginous migraine (18%), and benign paroxysmal positional vertigo (BPPV; 16%), whereas for dizziness patients, the top 3 were BPPV (35%), vertiginous migraine (24%), and vestibular neuronitis (24%). When the audiogram was performed, it was reported as "normal hearing" in both ears 20% of the time in tinnitus and dizziness patients and 30% in dizziness patients. When performed, the ENG showed normal caloric function in both ears most of the time and at least a 25% weakness in the clinically affected ear 35% of the time in tinnitus and dizziness patients and 25% in dizziness patients.
Discussion Summary
The primary objective of the ODC project was to test the research infrastructure through deployment of a descriptive, epidemiologic study on tinnitus and dizziness. The project, now successfully executed and completed, provides the needed proof of concept of the functionality and processes initially adopted in the CHEER community-based research network. The data described here are an important by-product of testing the operational metrics of CHEER. Notwithstanding that the study was not structured for the purpose of reaching a target enrollment or hypothesis testing, the success of this project and the resulting data further advance CHEER's mission of becoming the national resource for practice-based research in hearing and communicative sciences.
Context in the Literature
Additional credibility for the data itself is apparent when comparing results with those seen in the literature. In a review of epidemiologic studies published on tinnitus from 1993 to 2003, 10 findings across the literature include the following: age and sex were not consistently associated with prevalence of tinnitus; hearing loss was consistently associated with tinnitus; bilateral tinnitus was more common than unilateral, with leftsided tinnitus typically reported more than right; and clinical risk factors associated with tinnitus included depression. In our data, there was a close to equal split in sex for tinnitus patients, and the average age was 54. Our data indicate that normal hearing in both ears only was noted one-fifth of the time, in concert with the findings in the review. Similarly, we also found that bilateral tinnitus was more common (44%) than unilateral and that left-sided tinnitus was reported more often than rightsided (22% vs 20%). Thirty-eight patients (9%) indicated using antidepressants as a treatment strategy, potentially suggesting an association between tinnitus and depression. The review also pointed out the need for larger studies and the need for a more diverse patient population in terms of race and ethnicity. Our patient demographics show some diversity, with 14% of tinnitus patients indicating a race other than white. The patient demographics for the diseases in this study are consistent with the overall patient demographics at the participating sites. However, for future studies, the incorporation of a more diverse patient population through focused site recruitment is in progress for the CHEER network. Neuhauser et al 2, 3 reported dizziness and vertigo prevalence higher in women than in men in the general population. Our study supports this statistic; 71% of our dizziness patients were women, compared with the overall pool of respondents where 61% were women. Bronstein et al 4 reported the considerable impact of dizziness on social and work life. We found this to be true as 39% of dizziness patients reported having more than 10 episodes of vertigo, and 24% had missed more than 10 days of work in the past month. Bronstein et al found that half of the patients affected by dizziness feel a substantial drop in their efficiency at work, so much so that 25% may give up or change their work as a result. A 2010 report by Hegemann and Palla 11 reviewed recent advances in the field of neurotology, focusing on vestibular tests. They found that although there have been improvements, treatment options are still limited. The ability of the CHEER network to recruit large volumes of patients in a timely fashion across multiple sites could provide the necessary resource to explore treatment options further.
Limitations
Given that the primary goal of the ODC project was to implement and test the processes adopted by the CHEER infrastructure, the data presented here are both limited and robust. Conceptually, we can begin to see and describe disease patterns of tinnitus and dizziness that should be considered in the design of future research efforts. Because this data collection exercise was admittedly not hypothesis driven by the diseases, we have intentionally avoided database mining and statistical manipulations for correlations or conclusions that might be overinterpreted. We only describe the data in this report and propose interesting observations that might lead curious clinician-scientists to collaboratively explore practicebased research networks such as CHEER.
Future Work
The power and expediency of the CHEER network in recruiting ample patient sizes across a diverse set of practices and geographic locations are real. In the ODC study, we enrolled 1532 (427 tinnitus; 527 dizziness; 443 both tinnitus and dizziness) patients in 8 months across 16 sites. In contrast to this metric, the development of the THI was based on recruitment of 84 patients in the item development phase and 66 patients in the validation phase across 2 sites. 7 Similarly, in the development of the DHI, 8 the final version of the tool was administered to 106 consecutive patients at 1 site to demonstrate internal consistency reliability. In a review of randomized controlled trials in tinnitus and dizziness, the vast majority included fewer than 100 patients, and regardless of sample size, most are single-site studies. For comparative effectiveness research, studies aimed at subtyping, profiling, and stratifying patients are a necessary precursor. In addition, research translation and generalizability are facilitated by involving community sites and diverse populations in research.
The data are also valuable in serving as the foundation for developing research questions and protocols. Questions and future research opportunities could include the following:
1. What is the interassociation between disability, audiometric information, patient-reported quality of life, and symptoms? 2. How often are first-line treatments tried before seeking specialist consultation with hearing examination and evaluation? 3. What are the relevant patient characteristics and exam findings that are most important in subtyping dizziness and/or tinnitus suffers, and how might this provide information on fundamental pathophysiology of their disease and effective treatment options?
Further work in patient profiling and subcategorization needs to be a priority to guide development and conduct of future rigorous treatment trials. This is particularly true in the setting of high public health impact disease or disease symptoms that still have unclear etiologies and likely represent a collection of disorders. We must explore the texture of disease and disease presentations so that treatments are effective and acceptable to health care providers and patients.
The data here are robust in their descriptive and exploratory value, and what they predict can be accomplished in the future with adequate resources and through collaboration of academic medical centers with community partnerships. We believe that engagement and success at this grassroots level are essential to future research efforts and key steps to translating research into practice.
